Position in ALVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$43,117
New position
Shares Held
11,685
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 72 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,705,244,386 across 43 Drug Manufacturers - Specialty & Generic names. ALVO ranks #42 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,003,981 | $287,726,073 | |
| 2 | VTRS |
Viatris Inc
|
13,567,342 | $215,449,390 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
974,279 | $164,204,982 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
297,162 | $161,011,285 | |
| 5 | ALKS |
Alkermes plc.
|
2,335,117 | $122,360,130 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,553,213 | $87,444,571 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
2,453,787 | $85,072,795 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
665,457 | $73,825,799 |
All Filings in ALVO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,117 | 11,685 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||